Experienced in Diabetic Retinopathy

Dr. Kang Zhang

Ophthalmology
9415 Campus Point Dr, Mc0946, 
La Jolla, CA 
Experienced in Diabetic Retinopathy
9415 Campus Point Dr, Mc0946, 
La Jolla, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kang Zhang is an Ophthalmologist in La Jolla, California. Dr. Zhang is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Geographic Atrophy.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Ophthalmology
Licenses
Ophthalmology in UT
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

9415 Campus Point Dr, Mc0946, La Jolla, CA 92037

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Clinical and Genetic Assessment of Treatment Response in Patients With Age-related Macular Degeneration Using Intravitreal Aflibercept Injection
Clinical and Genetic Assessment of Treatment Response in Patients With Age-related Macular Degeneration Using Intravitreal Aflibercept Injection
Enrollment Status: Completed
Publish Date: March 25, 2021
Intervention Type: Drug
Study Phase: Phase 4
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS)
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab (COMPASS)
Enrollment Status: Terminated
Publish Date: August 28, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
VEGF and HTRA1 DNA Polymorphisms in Neovascular AMD Pathogenesis and Response to Lucentis
VEGF and HTRA1 DNA Polymorphisms in Neovascular AMD Pathogenesis and Response to Lucentis
Enrollment Status: Completed
Publish Date: August 14, 2019
Intervention Type: Drug
Study Phase: Phase 4
Genetic Assessment of Early to Late macuLar dEgeneration studY 2
Genetic Assessment of Early to Late macuLar dEgeneration studY 2
Enrollment Status: Completed
Publish Date: June 21, 2019
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Enrollment Status: Completed
Publish Date: April 28, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

6 Total Publications

In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 01, 2020
Similar Doctors
Distinguished in Diabetic Retinopathy
Dr. Mauricio E. Pons
Ophthalmology
Distinguished in Diabetic Retinopathy
Dr. Mauricio E. Pons
Ophthalmology

California Retina Associates, Lp

835 3rd Ave, Suite A, 
Chula Vista, CA 
 (19.8 miles away)
619-425-7755
Languages Spoken:
English
See accepted insurances

Mauricio Pons is an Ophthalmologist in Chula Vista, California. Dr. Pons is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Kallikrein Hypertension, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Distinguished in Diabetic Retinopathy
Dr. Tayson Delengocky
Ophthalmology
Distinguished in Diabetic Retinopathy
Dr. Tayson Delengocky
Ophthalmology

California Retina Associates, Lp

835 3rd Ave, Suite A, 
Chula Vista, CA 
 (19.8 miles away)
619-425-7755
Languages Spoken:
English
See accepted insurances

Tayson Delengocky is an Ophthalmologist in Chula Vista, California. Dr. Delengocky is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Glaucoma.

Distinguished in Diabetic Retinopathy
Dr. Majid Mani
Ophthalmology
Distinguished in Diabetic Retinopathy
Dr. Majid Mani
Ophthalmology

California Retina Associates, Lp

835 3rd Ave, Suite A, 
Chula Vista, CA 
 (19.8 miles away)
619-425-7755
Languages Spoken:
English
See accepted insurances

Majid Mani is an Ophthalmologist in Chula Vista, California. Dr. Mani is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Interstitial Keratitis, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zhang's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile